The Frequency of Thyroid Diseases in Women With Breast Cancer
Completed
- Conditions
- Breast CancerThyroid Diseases
- Interventions
- Device: thyroid USG was perform, blood samples were taken for the meausurement of thyroid hormone and autoantibodies
- Registration Number
- NCT04406779
- Lead Sponsor
- Uşak University
- Brief Summary
Breast cancer and thyroid disorders are important health challenges commonly encountered in women. The relationship between both conditions still remains unknown. In this study, the frequency of thyroid diseases was investigated in breast cancer patients
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 160
Inclusion Criteria
- women, the age between 18-65 years who were diagnosed with breast cancer, but not underwent surgery, radiotherapy or chemothreapy were included into the study
Exclusion Criteria
- Those with pregnancy, known liver and renal failure, the history of any malignancy other than breast cancer, undergoing a surgical operation due to breast cancer, also those receiving chemotherapy/radiotherapy for the same reason or undergoing partial or complete thyroid surgery or a surgical operation within the past 6 months, and also the patients taking oral anti-diabetic medication, insulin, steroids, thiazide, anti-psychotics and immuno-suppressive medicines affecting the levels of blood glucose, insulin and IR, smokers and those consuming alcohol were excluded
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Control thyroid USG was perform, blood samples were taken for the meausurement of thyroid hormone and autoantibodies Healthy patients without breast cancer Patients with breast cancer thyroid USG was perform, blood samples were taken for the meausurement of thyroid hormone and autoantibodies Patients with breast cancer
- Primary Outcome Measures
Name Time Method to investigate the frequency of thyroid diseases in breast cancer patients. 1 year
- Secondary Outcome Measures
Name Time Method